Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Interaction of cationic lipid vaccines with cells of the adaptive immune system

McEwen, Lisa Marie (2009) Interaction of cationic lipid vaccines with cells of the adaptive immune system. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Primary Text

Download (15MB) | Preview


When the cationic lipid DOTAP (1,2-dioleyltrimethylammoniumpropane) is used to encapsulate an antigenic peptide from the human papillomavirus E7 oncogene (E7), the resultant DOTAP/E7 particles act as a therapeutic vaccine to cause tumor regression through an antigen-specific immune response when the vaccine is injected into mice bearing E7-positive TC-1 tumors. Of critical importance, the DOTAP works as both a delivery vehicle and an adjuvant without induction of a pro-inflammatory cytokine response in vivo. It is hypothesized the antigen specific immune response is mediated by dendritic cells in vivo. To that end, the interaction of murine bone marrow-derived dendritic cells (BMDC) with the vaccine in vitro was investigated. When BMDC were incubated in the presence of DOTAP or the DOTAP/E7 vaccine, there was a dose and time-dependent upregulation of co-stimulatory molecule expression, indicating that BMDC were activated by the cationic lipid DOTAP. Further experiments indicated that BMDC were capable of internalizing DOTAP liposomes through many endocytic routes and the vaccine trafficked through the vacuolar pathway. An indirect method was used validate antigen presentation by BMDC, wherein the generation of antigen specific effector cells after incubation of CD8+ T lymphocytes, purified from the spleens of naïve mice, with fixed dendritic cells that had been activated by the vaccine, was examined. Not surprisingly, the DOTAP/E7 therapeutic vaccine was capable of initiating the generation of effector CD8+ T lymphocytes in vitro through a conventional mechanism, which requires dendritic cell activation and presentation of the peptide antigen. Interestingly, it was found the same simple vaccine was capable of generating antigen specific effectors in vitro in the absence of antigen presenting cells in a novel pathway of effector generation, based on the expression of CD8 on the cell surface, T cell receptors that recognize a specific peptide antigen/MHC complex as well as an antigen-specific increase in IFN-γ production. Further studies revealed a possible mechanism for this novel pathway. Taken as a whole, these observations may lead to additional applications of DOTAP both in vitro and in vivo to modulate the immune response toward the correction of a variety of diseases.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
McEwen, Lisa Marielisaluvsciens@gmail.com0000-0002-0943-0838
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairHuang,
Committee MemberFalo, Louislof2@pitt.eduLOF2
Committee MemberRobbins, Paulprobb@pitt.eduPROBB
Committee MemberKhan, Saleemkhan@pitt.eduKHAN
Committee MemberDuensing, Stefanduensing@pitt.eduDUENSING
Date: 7 August 2009
Date Type: Completion
Defense Date: 30 July 2009
Approval Date: 7 August 2009
Submission Date: 6 August 2009
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Institution: University of Pittsburgh
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: activation; antigen presenting cell; APC; CD8+; confocal microscopy; dendritic cell; DOTAP; effector; endocytosis; flow cytometry; LPD; surrogate
Other ID:, etd-08062009-100439
Date Deposited: 10 Nov 2011 19:57
Last Modified: 12 Jan 2018 17:02


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item